A Pure Estrogen Antagonist Inhibits Cyclin E-Cdk2 Activity in MCF-7 Breast Cancer Cells and Induces Accumulation of p130-E2F4 Complexes Characteristic of Quiescence
Open Access
- 1 December 2000
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 275 (49) , 38221-38229
- https://doi.org/10.1074/jbc.m004424200
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Nuclear Receptor Coregulators: Cellular and Molecular BiologyEndocrine Reviews, 1999
- Ligand-Independent Recruitment of SRC-1 to Estrogen Receptor β through Phosphorylation of Activation Function AF-1Molecular Cell, 1999
- Tamoxifen for early breast cancer: an overview of the randomised trialsThe Lancet, 1998
- Steroid hormone receptors: Many Actors in search of a plotCell, 1995
- Analysis of estrogen receptor function in vitro reveals three distinct classes of antiestrogensMolecular Endocrinology, 1995
- Comparison of the Effects of a Pure Steroidal antiestrogen With Those of Tamoxifen in a Model of Human Breast CancerJNCI Journal of the National Cancer Institute, 1995
- D-type cyclinsTrends in Biochemical Sciences, 1995
- Response to a specific antioestrogen (ICI 182780) in tamoxifen-resistant breast cancerThe Lancet, 1995
- Antiestrogen Resistance: Mechanisms by Which Breast Cancer Cells Undermine the Effectiveness of Endocrine TherapyJNCI Journal of the National Cancer Institute, 1991
- Effects of antioestrogens on the proliferation of MCF-7 human breast cancer cellsJournal of Molecular Endocrinology, 1989